🇺🇸 Amphastar Pharmaceuticals, Inc.
Forum topic · AMPH · Company page: financials, ownership and filings
Join the discussion on Amphastar Pharmaceuticals, Inc.
Loading…
Results announced on 5 November 2026
Amphastar Pharmaceuticals, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $208 million (up 8% from a year earlier) and net income of $38 million (up 118% from a year earlier).
Mutual funds: 206 funds hold $298 million
206 mutual funds in 1 country hold shares of Amphastar Pharmaceuticals, Inc. worth $298 million, about 35.1% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 69 funds added shares and 90 sold; on balance they sold $27 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.